Log In
BCIQ
Print this Print this
 

PF-06425090

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionUndisclosed vaccine against Clostridium difficile
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationClostridium
Indication DetailsPrevent Clostridium difficile-associated disease (CDAD); Treat clostridium difficile colitis
Regulatory Designation U.S. - Fast Track (Prevent Clostridium difficile-associated disease (CDAD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today